Fentanyl analogs: structure-activity-relationship study. 2009

S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, Dr Subotica 1, Belgrade, Serbia. svuckovic@med.bg.ac.rs

Fentanyl is the prototype of the 4-anilidopiperidine class of synthetic opioid analgesics. This study was aimed to review the structure-activity-relationship (SAR) of fentanyl analogs substituted in the position 3, or 4 of the piperidine ring. Pharmacological results show that the groups in position 3 of the piperidine ring, which are larger than methyl, severely reduce the analgesic potency compared to fentanyl. It is likely that the steric factor alone (i.e. voluminosity of the group and cis/trans isomerism), rather than the polarity and/or chemical reactivity, plays a crucial role in the analgesic potency of this series. Although the duration of action, in general, does not depend on the stereochemistry, longer action of the most potent 3-alkyl fentanyl analogs such as cis-3-methyl- and cis-3-ethyl fentanyl, is more likely influenced by pharmacodynamic, rather than pharmacokinetic variables. Also, it is possible that the introduction of a functional group such as 3-carbomethoxy reduces the duration of action by altering pharmacokinetic properties. SAR findings obtained by evaluating the neurotoxic effects of fentanyl analogs substituted in the position 3 of the piperidine ring parallel the SAR findings on analgesia in regard to potency and duration of action. This might suggest that similar receptors are involved in producing both antinociceptive and neurotoxic effects of these drugs. It appears that both the potency and the duration of action in the series of fentanyl analogs substituted in position 4 of the piperidine ring is influenced only by the steric requirement and not by the chemical nature of the substituent.

UI MeSH Term Description Entries
D005283 Fentanyl A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) Phentanyl,Duragesic,Durogesic,Fentanest,Fentanyl Citrate,Fentora,R-4263,Sublimaze,Transmucosal Oral Fentanyl Citrate,R 4263,R4263
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
August 1988, Research communications in chemical pathology and pharmacology,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
January 1992, Yao xue xue bao = Acta pharmaceutica Sinica,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
July 2011, Pakistan journal of biological sciences : PJBS,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
January 1991, Journal de pharmacie de Belgique,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
October 2011, Indian journal of biochemistry & biophysics,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
December 2015, Bioorganic & medicinal chemistry letters,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
January 1971, Pharmacology,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
August 1982, Gan,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
November 1965, Journal of medicinal chemistry,
S Vucković, and M Prostran, and M Ivanović, and Lj Dosen-Mićović, and Z Todorović, and Z Nesić, and R Stojanović, and N Divac, and Z Miković
December 1966, Journal of economic entomology,
Copied contents to your clipboard!